This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Emory University, M.d. Anderson Cancer Center, Sloan-Kettering Institute for Cancer Research. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2012-2022
Title: The Innovations of Daniel Kalman
Introduction
Daniel Kalman is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of medical research, particularly in the management of infectious diseases. With a total of 5 patents to his name, Kalman's work focuses on innovative treatments that have the potential to save lives.
Latest Patents
One of Kalman's latest patents involves the use of kinase inhibitors to manage tuberculosis and other infectious diseases. This disclosure relates to the use of kinase inhibitors to treat or prevent infectious diseases such as tuberculosis. In certain embodiments, the disclosure outlines methods of treating or preventing an infectious disease by administering an effective amount of a kinase inhibitor or other compounds to a subject in need. Specifically, it addresses methods for treating or preventing tuberculosis in subjects diagnosed with Mycobacterium tuberculosis (Mtb) that is resistant to multiple antibiotic agents.
Career Highlights
Throughout his career, Daniel Kalman has worked with prestigious institutions such as Emory University and the M.D. Anderson Cancer Center. His research has focused on developing innovative solutions to combat infectious diseases, showcasing his commitment to improving public health.
Collaborations
Kalman has collaborated with notable colleagues, including William G. Bornmann and Alyson Irene Swimm. These partnerships have further enhanced his research and contributed to the advancement of medical science.
Conclusion
Daniel Kalman's contributions to the field of infectious disease management through his innovative patents highlight his dedication to improving healthcare outcomes. His work continues to inspire future advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile